You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry: * Cultivate a career in biotechnology, with or without an MBA or Ph.D. * Fund and assemble a company * Manage research and development, alliances, and funding * Understand the diverse factors defining the biotechnology industry * Invest intelligently in biotechnology This second edition significantly expands upon the foundation laid by the first, updating recent developments and adding significantly more case studies, informative figures and tables.
Friedman provides a comprehensive fundamentals-based overview of the commercialization of biotechnology.
Make Better Decisions helps generic and branded companies alike find and evaluate drug market entry opportunities. Billions of dollars can change hands when key drug patents expire and generics launch. Brands, patients, physicians, payers, pharmacists, and other healthcare stakeholders must race to keep up.
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.
The 14th International Nitrogen Fixation Congress was held in Beijing, China from October 27th through November 1st, 2004. This volume constitutes the proceedings of the Congress and represents a compilation of the presentations by scientists from more than 30 countries around the World who came to Beijing to discuss the progress made since the last Congress and to exchange ideas and information. This year marked the 30th anniversary of the first Congress held in Pullman, Washington, USA, in 1974. Since then, this series of Congresses has met five times in North America (three in the United States and once each in Canada and Mexico), once in South America (Brazil), four times in Western Euro...
The Business of Biotechnology is an abridged edition of Building Biotechnology, a more advanced text widely used by biotechnology courses. This streamlined version presents a broad, accessible, and comprehensive overview of the business of biotechnology. The combined influences of scientific, legal, regulatory, political, and commercial factors shaping the biotechnology industry are defined and described, enabling you to understand and profit from the expanding influence of biotechnology.
Who would you run one hundred miles for? Caleb Oberest is an ultramarathon runner, who severed all ties to his family to race brutal 100-mile marathons across mountains. Shane Oberest is a sales rep for a cutting-edge biotechnology firm, creating new cures for the diseases of our time. Shane has spent his life longing to connect with his older brother, but the distance between them was always too vast. Caleb’s running group live by strict rules, but Caleb is breaking one of them. He has fallen in love with a new member and her infant daughter. When Caleb discovers that the baby has a fatal genetic disease, he reaches out to Shane. On the verge of becoming a father himself, Shane devises a plan that could save this baby and bring his lost brother home. But to succeed, both brothers will need to risk everything they have. And so each begins a dangerous race that will push them past their boundaries, and take all of Caleb’s legendry endurance to survive. Derek Sherman’s authentic, compelling story of ultramarathons, biotechnology, and family takes us deep into new worlds and examines how far we will go for the people we love.
Provides information on ways to identify and evaluate online business information sources and finding company and industry data on the Internet.
Intellectual property strategies to power your bottom line In the innovation economy, intellectual property is among the most valuable assets a business can have. IP strategy isn’t just incidental to success, it’s a key driver—research shows that IP-intensive small- and medium-sized enterprises are 60% more likely to achieve high growth. Myra Tawfik and Karima Bawa, two noted experts in the field of IP law and strategy, want to help you achieve greater success through the strategic deployment of your business’s IP. More than just patents, IP encompasses confidential information and trade secrets, industrial design, copyright, and trademarks. Understanding the unique IP portfolio of y...
This book provides a holistic picture of the digital age as it emerges in the 2010s. On the background of business analysis concepts from firm to megatrends and all business sectors of the World, the digital age of information systems and digital drivers are thoroughly laid out.